Australian Particle Therapy Clinical Quality Registry (ASPIRE) protocol (TROG 21.12): a multicentre prospective study on patients with rare tumours, treated with radiation therapy

Australian Particle Therapy Clinical Quality Registry (ASPIRE) protocol (TROG 21.12): a multicentre prospective study on patients with rare tumours, treated with radiation therapy

Introduction In 2020, the Australian Medical Services Advisory Committee (MSAC) recommended new proton beam therapy (PBT) item numbers be added to the Medicare Benefits Schedule. During the MSAC 1638 application process, MSAC recognised the uncertainties inherent in the cost-utility modelling of PBT...

Full description

Saved in:
Bibliographic Details
Main Authors: Hien Le, Scott Penfold, Sophie Jessop, Kelly Skelton, Peter Gorayski, Amber Murray, Daniel Hamilton, Adam Yeo, Eunji Hwang, Joshua Dass
Format: Article
Language:English
Published: BMJ Publishing Group 2024-11-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/11/e083044.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items